Prolactin induces MFG-E8 production in macrophages via transcription factor C/EBPβ-dependent pathway

被引:31
作者
Aziz, Md. Monowar [1 ]
Ishihara, Shunji [1 ]
Rumi, Mohammad Azharul Karim [2 ]
Mishima, Yoshiyuki [1 ]
Oshima, Naoki [1 ]
Kadota, Chikara [1 ]
Moriyama, Ichiro [1 ]
Li, Yong-Yu [1 ]
Rahman, Farzana Binte [1 ]
Otani, Aya [1 ]
Oka, Akihiko [1 ]
Ishimura, Norihisa [1 ]
Kadowaki, Yasunori [1 ]
Amano, Yuji [3 ]
Kinoshita, Yoshikazu [1 ]
机构
[1] Shimane Univ, Sch Med, Dept Internal Med 2, Izumo, Shimane, Japan
[2] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA
[3] Shimane Univ Hosp, Div Gastrointestinal Endoscopy, Izumo, Shimane, Japan
关键词
C/EBP beta; MFG-E8; phagocytosis; prolactin; apoptosis;
D O I
10.1007/s10495-008-0201-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lactogenic hormone prolactin (PRL) regulates milk protein gene expression in mammary glands. To maintain homeostatic balance in the body, milk fat globule epidermal growth factor 8 (MFG-E8) is vital for phagocytic clearance of apoptotic cells. We investigated the effects of PRL on MFG-E8 expression in macrophages by evaluating its promoter function. Macrophages were stimulated with PRL, and the expression of MFG-E8 was determined using real-time PCR and Western blotting. The role of MFG-E8 on phagocytosis of apoptotic cells in PRL-treated macrophages was assessed using microscopy, while the response of PRL to MFG-E8 expression was evaluated using luciferase assay. Following treatment with PRL, significant up-regulations of the PRL receptor and MFG-E8 were observed in macrophages, though PRL-treated macrophages more efficiently engulfed apoptotic cells. The results of MFG-E8 promoter analysis showed considerable up-regulation of promoter activity in macrophages following PRL treatment and results from mutation analysis of the MFG-E8 promoter suggested that the C/EBP beta binding site was responsible for PRL-induced activation of the MFG-E8 promoter. C/EBP beta activity was found to be up-regulated in PRL-treated cells as revealed by an electrophoretic mobility shift assay (EMSA). In conclusion, PRL is a potent inducer of MFG-E8 expression in macrophages, while its effect is mediated by the presence of a responsive element in the MFG-E8 promoter.
引用
收藏
页码:609 / 620
页数:12
相关论文
共 47 条
[1]  
Aoki N., 1997, BIOCHIM BIOPHYS ACTA, V1334, P182
[2]   RETRACTED: Regulation and functional relevance of milk fat globules and their components in the mammary gland (Retracted Article) [J].
Aoki, Naohito .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2006, 70 (09) :2019-2027
[3]   Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice [J].
Asano, K ;
Miwa, M ;
Miwa, K ;
Hanayama, R ;
Nagase, H ;
Nagata, S ;
Tanaka, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) :459-467
[4]   Mfge8 is critical for mammary gland remodeling during involution [J].
Atabai, K ;
Fernandez, R ;
Huang, XZ ;
Ueki, I ;
Kline, A ;
Li, Y ;
Sadatmansoori, S ;
Smith-Steinhart, C ;
Zhu, WM ;
Pytela, R ;
Werb, Z ;
Sheppard, D .
MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (12) :5528-5537
[5]   Prolactin as an autocrine/paracrine growth factor in human cancer [J].
Ben-Jonathan, N ;
Liby, K ;
McFarland, M ;
Zinger, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (06) :245-250
[6]   SUPPRESSION OF MACROPHAGE ACTIVATION AND LYMPHOCYTE-T FUNCTION IN HYPOPROLACTINEMIC MICE [J].
BERNTON, EW ;
MELTZER, MS ;
HOLADAY, JW .
SCIENCE, 1988, 239 (4838) :401-404
[7]  
CARLO RD, 1995, ENDOCRINOLOGY, V136, P4713
[8]   Recent developments in the understanding of antinuclear autoantibodies [J].
Casiano, CA ;
Tan, EM .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (04) :308-313
[9]   CCAAT/ENHANCER-BINDING PROTEIN ISOFORM-BETA AND ISOFORM-DELTA ARE EXPRESSED IN MAMMARY EPITHELIAL-CELLS AND BIND TO MULTIPLE SITES IN THE BETA-CASEIN GENE PROMOTER [J].
DOPPLER, W ;
WELTE, T ;
PHILIPP, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :17962-17969
[10]  
Gigliotti AP, 1998, J CELL PHYSIOL, V174, P232, DOI 10.1002/(SICI)1097-4652(199802)174:2<232::AID-JCP10>3.0.CO